Customers and Other Financing and Non-Financing Receivable |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trade and other receivables [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Customers and Other Financing and Non-Financing Receivable | CUSTOMERS AND OTHER FINANCING AND NON-FINANCING RECEIVABLE As of March 31, 2025 and December 31, 2024, accounts receivable and other receivables were as follows: A. Customers
(1) As of March 31, 2025 and December 31, 2024, customers include impairment of Ps.25,530,656 and Ps.24,396,664, respectively. During the three-month period ended March 31, 2025 and the twelve-month period ended December 31, 2024, the impairment charge was Ps.1,133,990 and Ps.15,438,558, respectively. Customers and other accounts receivable, net are presented separately in the statement of financial position to conform the financial position more clearly. B. Other financing and non-financing receivable
(1)Includes Ps. (785,116) and Ps. (788,453) of impairment, as of March 31, 2025 and December 31, 2024, respectively.
|